Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittermaier, C.
Right arrow Articles by Moser, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittermaier, C.
Right arrow Articles by Moser, G.
Psychosomatic Medicine 66:79-84 (2004)
© 2004 American Psychosomatic Society


ORIGINAL ARTICLES

Impact of Depressive Mood on Relapse in Patients With Inflammatory Bowel Disease: A Prospective 18-Month Follow-Up Study

Christian Mittermaier, MD*, Clemens Dejaco, MD*, Thomas Waldhoer, PhD, Anna Oefferlbauer-Ernst, MD, Wolfgang Miehsler, MD, Markus Beier, MD, Wolfgang Tillinger, MD, Alfred Gangl, MD and Gabriele Moser, MD

From the Department of Medicine IV, Division of Gastroenterology and Hepatology (C.D., A.O. W.M., M.B., W.T., A.G., G.M.), Department of Physical Medicine and Rehabilitation (C.M.), and Department of Epidemiology, Institute of Tumor Biology (T.W.), University Hospital of Vienna, Vienna, Austria.

Address correspondence and reprint requests to Dr. Clemens Dejaco, Division of Gastroenterology and Hepatology, Department of Internal Medicine IV, University Hospital, AKH, Waehringer Guertel 18-20, A-1090 Vienna, Austria. E-mail: clemens.dejaco{at}akh-wien.ac.at

OBJECTIVE: There is evidence of an interaction between psychological factors and activity of inflammatory bowel disease (IBD). We examined the influence of depressive mood and associated anxiety on the course of IBD over a period of 18 months in a cohort of patients after an episode of active disease.

METHODS: In this prospective, longitudinal, observational study, 60 patients (37 women and 23 men) with clinically inactive IBD (Crohn disease, n = 47, 78%; ulcerative colitis, n = 13, 22%) were enrolled after a flare of disease. Psychological status, health-related quality of life (HRQOL), and disease activity were evaluated at baseline and then every 3 months for a period of 18 months by means of clinical and biological parameters, the Beck Depression Inventory (BDI), the Spielberger State-Trait Anxiety Inventory, the Inflammatory Bowel Disease Questionnaire, the Perceived Stress Questionnaire, and the Rating Form of Inflammatory Bowel Disease Patients Concerns.

RESULTS: At baseline, depression (BDI >=13 points) was found in 17 of 60 (28%) patients. Thirty-two patients (59%) experienced at least one relapse during the 18 months of follow-up. Regression analysis showed a significant correlation between BDI scores at baseline and the total number of relapses after 12 (p < .01) and 18 months (p < .01) of follow-up. Furthermore, depression scores at baseline correlated with the time until the first recurrence of the disease (p < .05). Anxiety and low HRQOL were also related with more frequent relapses during follow-up (p < .05 and p < .01, respectively).

CONCLUSIONS: Psychological factors such as a depressive mood associated with anxiety and impaired HRQOL may exert a negative influence on the course of IBD. Therefore, assessment and management of psychological distress should be included in clinical treatment of patients with IBD.

Key Words: inflammatory bowel disease, • depressive mood, • anxiety, • disease activity, • health-related quality of life.

Abbreviations: BDI = Beck Depression Inventory;; CAI = colitis activity index;; CD = Crohn disease;; CDAI = Crohn disease activity index;; ESR = erythrocyte sedimentation rate;; HRQOL = health-related quality of life;; IBD = inflammatory bowel disease;; IBDQ = Inflammatory Bowel Disease Questionnaire;; PSQ = Perceived Stress Questionnaire;; RFIPC = Rating Form of Inflammatory Bowel Disease Patient Concerns;; STAI = Spielberger State-Trait Anxiety Inventory;; UC = ulcerative colitis.




This article has been cited by other articles:


Home page
PsychosomaticsHome page
A. Agostini, F. Rizzello, G. Ravegnani, P. Gionchetti, R. Tambasco, M. Ercolani, and M. Campieri
Parental Bonding and Inflammatory Bowel Disease
Psychosomatics, January 1, 2010; 51(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Bitton, P L Dobkin, M D Edwardes, M J Sewitch, J B Meddings, S Rawal, A Cohen, S Vermeire, L Dufresne, D Franchimont, et al.
Predicting relapse in Crohn's disease: a biopsychosocial model
Gut, October 1, 2008; 57(10): 1386 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
U. Weik, A. Herforth, V. Kolb-Bachofen, and R. Deinzer
Acute Stress Induces Proinflammatory Signaling at Chronic Inflammation Sites
Psychosom Med, October 1, 2008; 70(8): 906 - 912.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
D. H. Novack, O. Cameron, E. Epel, R. Ader, S. R. Waldstein, S. Levenstein, M. H. Antoni, and A. R. Wainer
Psychosomatic Medicine: The Scientific Foundation of the Biopsychosocial Model
Acad Psychiatry, October 1, 2007; 31(5): 388 - 401.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M. Lukas, M. Bortlik, and Z. Maratka
What is the origin of ulcerative colitis? Still more questions than answers.
Postgrad. Med. J., October 1, 2006; 82(972): 620 - 625.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Demaude, C Salvador-Cartier, J Fioramonti, L Ferrier, and L Bueno
Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction
Gut, May 1, 2006; 55(5): 655 - 661.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R Caprilli, M A Gassull, J C Escher, G Moser, P Munkholm, A Forbes, D W Hommes, H Lochs, E Angelucci, A Cocco, et al.
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
Gut, March 1, 2006; 55(suppl_1): i36 - i58.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J E Mawdsley and D S Rampton
Psychological stress in IBD: new insights into pathogenic and therapeutic implications
Gut, October 1, 2005; 54(10): 1481 - 1491.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
G. E. Miller, N. Rohleder, C. Stetler, and C. Kirschbaum
Clinical Depression and Regulation of the Inflammatory Response During Acute Stress
Psychosom Med, September 1, 2005; 67(5): 679 - 687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Psychosomatic Society